ACM  >> Vol. 5 No. 3 (September 2015)

    心血管疾病风险评估研究的概况
    Survey of the Risk Assessment of Cardiovascular Disease

  • 全文下载: PDF(380KB) HTML   XML   PP.177-182   DOI: 10.12677/ACM.2015.53028  
  • 下载量: 1,535  浏览量: 7,718   国家科技经费支持

作者:  

李雪平,谢艳虹,许朝霞,王忆勤:上海中医药大学基础医学院,上海

关键词:
心血管病危险因素风险评估四诊信息Cardiovascular Disease Risk Factor Risk Assessment Information from TCM Four Diagnostic Methods

摘要:

心血管疾病因其高发病率、高致死率,成为世界范围内最大的疾病负担。作者通过查阅国内外大量相关文献,比较目前常用的心血管病风险评估工具如Framingham风险评估、美国胆固醇教育计划成人治疗组第三次指南(NCEP ATP III)、欧洲系统性冠心病风险评估、英国QRISK心血管风险评估、Reynolds风险评分等,发现CVD风险评估模型随着风险因素的不断发现而不断完善,同时也存在不同程度的局限性。我国尚缺乏对CVD进行全面系统、综合传统风险因素和遗传因素的有效风险评估手段,进而提出将中医四诊信息客观参数运用到CVD风险因素评估中,以期为我国疾病风险评估研究提供新的思路。

Cardiovascular diseases become the biggest burden of disease worldwide because of its high inci-dence and mortality. By collecting a large number of related literatures and comparing the present commonly used cardiovascular disease risk assessment tools such as Framingham risk assessment, the United States cholesterol program adult treatment group report (NCEP ATP III), Systematic Coronary Risk Evaluation in Europe, the British QRISK cardiovascular risk algorithm, Reynolds Risk Score and so on, we find that CVD risk assessment models are continuously improved with more risk factor being found and also there are different degrees of limitations. As the effective and comprehensive risk assessment of CVD, which takes conventional risk factors and genetic factors into consideration, is not available in China, we thus put forward the new research thinking that combines traditional Chinese medical method, information from TCM Four diagnostic methods, with CVD risk assessment to study the risk assessment of disease in our country.

文章引用:
李雪平, 谢艳虹, 许朝霞, 王忆勤. 心血管疾病风险评估研究的概况[J]. 临床医学进展, 2015, 5(3): 177-182. http://dx.doi.org/10.12677/ACM.2015.53028

参考文献

[1] 袁绍华, 张新超 (2011) 心血管疾病风险评估方法及存在问题. 中国心血管杂志, 16, 223-226.
[2] 刘志学, 胡洋 (2014) 《中国心血管病报告2013》. 中国医药导报, 26, 117.
[3] 陈伟伟, 高润霖, 刘力生, 等 (2014) 中国心血管病报告2013概要. 中国循环杂志, 29, 487-491.
[4] 吴海云, 潘平, 何耀 (2007) 我国成年人糖尿病发病风险评估方法. 中华健康管理学杂志, 1, 95-98.
[5] 吴丹, 李盼, 张元亭 (2014) 基于健康信息的急性心血管疾病早期预警. 科研信息化技术及应用, 5, 59-72.
[6] 徐艳芳, 任澎 (2015) 心血管疾病危险因素研究新进展. 心血管康复医学杂志, 24, 98-100.
[7] 王忠祥, 王发祥 (2015) 心血管疾病非传统危险因素的研究进展. 临床急诊杂志, 15, 82-84.
[8] Kannel, W.B., Dawber, T.R., Kagan, A., Revotskie, N. and Stokes, J. (1961) Factors of risk in the development of coronary heart disease—Six year follow up experience. The Framingham study. Annals of Internal Medicine, 55, 33-50.
http://dx.doi.org/10.7326/0003-4819-55-1-33
[9] 刘静, 赵冬 (2009) Framingham心脏研究的过去、现在和将来. 中华心血管病杂志, 37, 470-471.
[10] Truett, J., Cornfield, J. and Kannel, W. (1967) A mmultivariate analysis of the risk of coronary heart disease in framingham. Journal of Chronic Diseases, 20, 511-524.
http://dx.doi.org/10.1016/0021-9681(67)90082-3
[11] Goff, D.C., Lloyd-Jones, D.M., Bennett, G., Coady, S., D’Agostino, R.B., Gibbons, R., et a1. (2014) 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circu-lation, 129, S49-S73.
[12] 陈红, 宋俊贤 (2014) 心血管风险评估: 新指南、新工具. 中国心血管杂志, 19, 330-333.
[13] National Cholesterol Education Program Expert on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adults Treatment Panel Ⅲ). JAMA, 285, 2486-2497.
http://dx.doi.org/10.1001/jama.285.19.2486
[14] Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., May, M. and Brindle, P. (2007) Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort study. BMJ, 335, 136.
http://dx.doi.org/10.1136/bmj.39261.471806.55
[15] Ridker, P.M., Buring, J.E., Rifai, N. and Cook, N.R. (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score. JAMA, 297, 611-619.
http://dx.doi.org/10.1001/jama.297.6.611
[16] 世界卫生组织 (2008) 心血管疾病预防(心血管风险评估和管理袖珍指南). 世界卫生组织出版处, 日内瓦, 1-23.
[17] Wu, Y.-F., Liu, X.-Q., Li, X., Li, Y., Zhao, L.C., Chen, Z., et al. (2006) Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation, 114, 2217-2225.
http://dx.doi.org/10.1161/CIRCULATIONAHA.105.607499
[18] Zhang, X.-F., Attia, J., D’Este, C., Yu, X.-H. and Wu, X.-G. (2005) A risk score predicted coronary heart disease and stroke in a Chinese cohort. Journal of Clinical Epidemiology, 58, 951-958.
http://dx.doi.org/10.1016/j.jclinepi.2005.01.013
[19] 瞿岳云, 林院昌, 王云翔 (2006) 冠心病心绞痛脉象脉图与证素相关性临床研究. 湖南中医学院学报, 26, 31-33.
[20] 孙智山, 瞿岳云, 张翼 (2004) PCT干预对不稳定型心绞痛患者脉图参数的影响. 中华实用中西医杂志, 4, 3355.
[21] 吴喜庆, 陆小左 (2014) 冠心病中医客观化疗效评价方法研究. 辽宁中医杂志, 41, 1574-1583.